Foldax is addressing a key challenge recently highlighted by The Wall Street Journal: as minimally invasive TAVR procedures expand,...
Read moreFoldax Inc. was recently highlighted among a select group of companies shaping the next generation of heart valve replacement....
Read moreFoldax Inc., along with its local manufacturing partner Dolphin Life Science LLP, has released the TRIA Mitral Valve in India....
Read moreIn a landmark achievement for cardiac care, Fortis Escorts Heart Institute (FEHI), New Delhi, has successfully performed one of...
Read moreFoldax Inc. has officially launched its TRIA™ Mitral Valve in India, marking the world’s first polymer heart valve to...
Read moreFoldax Inc. is sharing compelling one-year results from India’s clinical trial of the TRIA Mitral Valve, showing a good...
Read moreFoldax® Inc. announced compelling one-year results from the India Clinical Trial of the TRIA™ Mitral Valve, showing a good...
Read moreFoldax Inc. announced that the Indian Central Drugs Standard Control Organization (CDSCO) approved its TRIA™ Mitral Valve. Dolphin Life...
Read moreFoldax is targeting India for the first approval of its polymer mitral surgical heart valve. The company spoke with...
Read moreFoldax®, Inc., a leader in the development of innovative, polymer heart valves, today announced positive 30-day results from a...
Read more